HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

OM

Outset Medical, Inc.

Healthcare — Medical Devices

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Buy 1.7 / 5 3 analysts
$3.75
+$0.75 (+25.00%)
Target: $7.67 (104.4%)

Price History

52-Week Range
Sign in to add OM to a watchlist or set price alerts.

Fundamentals

Market Cap$94.54M
P/E Ratio (TTM)-
Forward P/E-2.34
EPS (TTM)$-2.74
Dividend Yield-
Profit Margin-63.65%
Revenue Growth-6.30%
ROE-53.17%
Debt/Equity90.98
Recommendation Buy 1.7
Analyst Target$7.67
Analysts3
Next Earnings Aug 6, 2026 AMC
Indexes -

Technical Indicators

RSI (14)56.5
Beta1.94
SMA 20-
SMA 40-
52-Week High$21.36
52-Week Low$3.00
50-Day Avg$4.42
200-Day Avg$6.24
Avg Volume215.2K
Volume313.3K

Performance Analysis

NEUTRAL

OM presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($3.00), which could present a value opportunity.
+ RSI at 56.5 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 6.3% year-over-year.
- Operating at a loss with -63.7% margin.
+ Wall Street consensus is "Buy" from 3 analysts.
+ Average analyst target of $7.67 implies 104.4% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:24 UTC

Back to Screener Export Report